Press Releases Moderna, Inc.

Equities

MRNA

US60770K1079

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-06 pm EST			5-day change	1st Jan Change
52.52 ^USD	-2.43%		-1.96%	+78.09%

Mar. 05	Berenberg Raises Price Target on Moderna to $45 From $32, Keeps Hold Rating	MT
Mar. 04	US stocks close up on Iran diplomacy hopes; tech leads rebound	RE

Press Releases

Feb. 27	Moderna : Transcript (MRNA USQ Transcript 2026 01 13 3)	PU
Feb. 18	Moderna says the FDA will consider its new flu shot after resolving a public dispute	AQ
Feb. 13	Moderna : Earnings Transcript (MRNA USQ Transcript 2026 02 13)	PU
Feb. 13	Moderna : Earnings Presentation (ModernaQ25inal)	PU
Feb. 13	Moderna: Q4 Earnings Snapshot	AQ
Feb. 04	Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc.	AQ
Jan. 20	Moderna : Transcript (MRNA USQ Transcript 2026 01 13)	PU
Jan. 12	Moderna : Presentation (Moderna 2026 JPM Presentation 16 FINAL for web upload 78 )	PU
Jan. 12	Moderna : Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference	PU
Dec. 17	Moderna : to Present at the 44th Annual J.P. Morgan Healthcare Conference	PU
Dec. 12	Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance	AQ
Dec. 10	Nanexa and Moderna enter into license and option agreement for the development of PharmaShell®-based products	AQ
Nov. 24	Moderna : Transcript (MRNA USQ Transcript 2025 11 20 2)	PU
Nov. 20	Moderna : Presentation (Moderna 2025 Analyst Day FINAL PDF 48 54e4e7af)	PU
Nov. 20	Moderna : Presentation (Moderna 2025 Analyst Day FINAL PDF 48 )	PU
Nov. 20	Moderna : Secures $1.5 Billion Five-Year Credit Facility from Ares Management	PU
Nov. 06	Moderna : Transcript (MRNA USQ Transcript 2025 11 06 1)	PU
Nov. 06	Moderna : Presentation (Moderna 3Q25 Earnings Presentation)	PU
Nov. 06	Moderna: Q3 Earnings Snapshot	AQ
25-10-27	Moderna : Transcript (MRNA USQ Transcript 2025 10 17)	PU
25-10-22	Moderna : ID Week (Norovirus mRNA-1403 Phase 1 / 2 immunogenicity)	PU
25-10-22	Moderna : ID Week (Lyme mRNA 1982 & 1975 safety & immunogenicity)	PU
25-10-20	Moderna : ID Week (CMV mRNA-1647 in patients who have undergone hematopoietic cell transplant)	PU
25-10-20	Moderna : ID Week (RSV vaccine mRNA-1345 in solid organ transplant recipients)	PU
25-10-20	Moderna : ID Week (Pandemic flu mRNA-1018 safety and immunogenicity)	PU